MR-guided focused ultrasound developer InSightec has received an investment of $12.5 million from Shanghai GEOC Hengtong Investment Limited Partnership and Fortune China Limited.
The Chinese investment group purchased more than 6.4 million series D preferred shares, which represents approximately 5% of InSightec's share capital on a fully diluted basis, according to fellow InSightec shareholder Elbit Medical. Elbit now owns 33.3% on a fully diluted basis of InSightec.